Participation Form

We will notify the Study Coordinator for "Clinical Trial of Pembrolizumab (MK-3475) in Subjects with Advanced or Metastatic Urothelial Cancer," on your behalf, that you would like to participate in this study.

Please fill out the form below and click "Submit" to send a notification request.

or Cancel

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.